Scientific Library - Theratechnologies, Peptide-based therapy, GHRH, Synthetic Growth Hormone

Model and picture are being used for illustrative purposes only.

Peptides are active at low doses, highly specific and generally have a very good safety profile when used physiologically.

Scientific Library

Articles and posters

Metabolic Effects of Tesamorelin, a Growth Hormone-Releasing Factor Analogue, in HIV-infected Patients with Excess Abdominal Fat. A Pooled Analysis of 2 Phase 3 Trials. (PDF : 144.62 K)

November 11, 2009
Pharmacokinetic/Pharmacodynamic Evaluation of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor (GRF) Analog, Administered Subcutaneously Once Daily for 14 Consecutive Days in Healthy and HIV Positive Populations (PDF : 126.37 K)

June 12, 2009
Impact of Tesamorelin (TH9507), a Stabilized Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers (PDF : 45.7 K)

April 27, 2009
Atherogenic Lipid Profile in Treated HIV Patients with Increased Visceral Adiposity:Association with More Severe CVD Risk Parameters and Response to Tesamorelin (TH9507), a Growth Hormone-Releasing Factor (GRF) Analogue (PDF : 128.71 K)

February 9, 2009

Terms of use